Dr. Prosper Benhaim, MD

Dr. Benhaim practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Benhaim's NPI, 1669558615, was assigned on October 31, 2006. Dr. Benhaim graduated from UCSF School of Medicine in 1987. Dr. Benhaim holds California license G65324.

Dr. Benhaim's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Benhaim's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Benhaim is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Orthopaedic Surgery. Dmand AI also links Dr. Benhaim to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benhaim practices, 6 sites in all. Vendor and product names are available with a free account.

Hand surgery is Dr. Benhaim's primary specialty in the NPI Registry, under taxonomy code 207XS0106X. Dr. Benhaim is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Benhaim is licensed in California.

Dmand AI lists cancerous skin growth removal and chronic skin ulcer among the conditions Dr. Benhaim treats.

CMS data shows 5,484 Medicare services from Dr. Benhaim across 20 procedure codes in 2024, for 364 Medicare patients. Medicare paid $353,683 for them.

CMS counts 364 Medicare patients who saw Dr. Benhaim in 2024. The largest group is 65 to 74, with 178 patients. 75% of them have high cholesterol, and 69% have arthritis. 17% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Benhaim's median patient age at 64, with 52% women.

In 2024, Dr. Benhaim wrote 143 Medicare Part D claims for 81 patients. 94% of them were for generic drugs. CMS names the drug for 101 of them, across 4 drugs with 11 or more claims each, at $630 in total drug cost. In 2023, CMS named 80 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Benhaim for performance year 2024, reported as part of a group. Dr. Benhaim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Benhaim as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper limb (arm) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Benhaim, published from 2010 to 2024. 2010 was the busiest year, with 2. Dr. Benhaim's most frequent co-authors are Kodi K. Azari, FACS, MD, Tristan Layton Hartzell, MD and Lawrence Hurst, MD.

CMS Open Payments shows 529 general payments to Dr. Benhaim from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Endo Pharmaceuticals Inc. paid the most, $474,162.

Dmand AI lists 2 awards for Dr. Benhaim.

Dr. Benhaim graduated from UCSF School of Medicine in 1987. Dr. Benhaim is a member of AOA, American Association for Hand Surgery, American Association of Plastic Surgeons, ACS, American Society for Surgery of the Hand and ASPS.

Dr. Benhaim is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.